Trial intelligence / Profile preview

Wet-wrap therapy with diluted corticosteroids versus emollients in children with severe atopic dermatitis

NL-OMON21806Phase 4Recruiting

Sponsor
Havenziekenhuis
Start
Feb 2009
Countries
1
01

Overview

Phase 4, randomised, open-label trial of corticosteroids in atopic dermatitis (AD) (2 arms), sponsored by Havenziekenhuis. Primary endpoint: Change in objective SCORAD. Started Feb 2009; status: recruiting.

02

Drugs

corticosteroids
03

Conditions

atopic dermatitis (AD)

Beyond the preview

Go deeper on NL-OMON21806.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON21806.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call